Myeloid-derived suppressor cells in pancreatic cancer: more than a hidden barrier for antitumour immunity?
- 14 March 2014
- Vol. 63 (11), 1690-1691
- https://doi.org/10.1136/gutjnl-2014-306790
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- History of myeloid-derived suppressor cellsNature Reviews Cancer, 2013
- Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignanciesCancer Immunology, Immunotherapy, 2012
- Cellular Constituents of Immune Escape within the Tumor MicroenvironmentCancer Research, 2012
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic CancerCancer Cell, 2012
- Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic NeoplasiaCancer Cell, 2012
- Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growthCancer Immunology, Immunotherapy, 2012
- Myeloid derived suppressor cells in human diseasesInternational Immunopharmacology, 2011
- Increase in frequency of myeloid‐derived suppressor cells in mice with spontaneous pancreatic carcinomaImmunology, 2009
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing MicePublished by The American Association of Immunologists ,2008
- Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to InvasionCancer Research, 2007